| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5537091 | Vaccine | 2017 | 9 Pages |
Abstract
Higher concentrations of maternally-derived antibody-mediated complement deposition are associated with a decreased risk of GBS colonization in infants up to day 60-89 of life. Our findings are of relevance to establish thresholds for protection following vaccination of pregnant women with future GBS vaccines.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Kirsty Le Doare, Amadou Faal, Mustapha Jaiteh, Francess Sarfo, Stephen Taylor, Fiona Warburton, Holly Humphries, Jessica Birt, Sheikh Jarju, Saffiatou Darboe, Edward Clarke, Martin Antonio, Ebenezer Foster-Nyarko, Paul T. Heath, Andrew Gorringe,